Small Biotech Catapults To Record High On $10.6 Billion Deal – Investor’s Business Daily

GSK made an all-cash bid to buy the small cancer-focused biotech company for $10.6 billion.

#stockmarket #breaking

Leave a Reply

WP Twitter Auto Publish Powered By : XYZScripts.com